Clinical Trial Update: S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating celecoxib for high-grade cervical lesions and Stage 0 cervical cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia

Drugs mentioned

• CELEBREX (Celecoxib)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Stage 0 Cervical Cancer, High-grade Squamous Intraepithelial Lesion | Phase 2 | Status: WITHDRAWN